WRAP53 and head and neck carcinoma: However, contradictory reports from a separate clinical study suggest that higher nuclear expression of TCAB1 is associated with increased sensitization to radiotherapy, better disease-free progression and overall survival in both ovarian cancer [123], as well as in head and neck carcinoma [124, 125].